Last updated on July 2019

Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients


Brief description of study

To characterize the pharmacokinetics (PK) of naloxegol after single oral dose and through population PK in paediatric patients with opioid induced constipation (OIC) or at risk of OIC.

Clinical Study Identifier: NCT02099591

Find a site near you

Start Over